- -- 07 October 2008
- immatics won second prize in European Biotechnica Award 2008
- -- 14 July 2008
- immatics obtains important U.S. and European patents
- -- 09 July 2008
- immatics appoints Paul G. Higham as Chief Executive Officer
- -- 07 July 2008
- immatics receives 3 research grants totaling 1.4 mn € to advance its early-stage cancer immunotherapy programs
- -- 22 April 2008
- immatics launches Phase I/II study of IMA910 cancer vaccine in colorectal cancer
- -- 11 January 2008
- immatics opens office in Munich
immatics won second prize in European Biotechnica Award 2008
Tuebingen, October 7, 2008 – immatics biotechnologies GmbH is pleased to announce that it has won the second prize in the European Biotechnica Award 2008. The award was presented yesterday evening during the opening ceremony of the BIOTECHNICA in Hannover, Germany. Previously , immatics had been selected as one of three finalists by an international jury of acclaimed biotech professionals and representatives of the investment community. The major selection criteria were exceptional products and services with highly innovative potential for the life science market.
For more information please contact media@immatics.com or visit the BIOTECHNICA website.